Great progress has been made in the treatment of patients with idiopathic pulmonary fibrosis, but the use of molecular markers to implement precision medicine could revolutionize treatment in the near future.
2016 Daily Conference News
Get Free Access to Sessions
Extend your ATS International Conference experience. Get one year of free complimentary access* to more than 200 hours of select ATS 2016 scientific symposia webcasts in the Best of ATS Conference collection.
Stem Cells: Unveiling Their Promise for Lung Diseases
The use of stem cells to prevent and treat human diseases has led to unprecedented growth in regenerative medicine. Increasing evidence has shown that an individual’s own cells have the potential for development of stem cell-based therapeutic approaches.
Burden of Respiratory Disease on Migrants
The crisis in the Middle East has raised awareness about the challenges encountered by migrant populations, especially their access to health care. Migrant populations around the world, including those from Mexico and Latin America entering the United States, face similar challenges.
ATS Welcomes Decision on Shorter MDR-TB Regimen
On May 12, the World Health Organization released recommendations aimed to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through the use of a novel, rapid diagnostic test and a shorter, cheaper treatment regimen.
The ATS Center Shows Global Reach
Learn about all that the American Thoracic Society has to offer, including its activities around the world, at the ATS Center in Booth 937 in the Exhibit Hall at Moscone Center, Halls A-C (South Building, Lower Level). Be sure to visit from 8 a.m. to 2:45 p.m. on Tuesday.
Forums Celebrate Diversity and Inclusivity
Two popular forums gave attendees the opportunity to recognize and support diversity and women in the fields of pulmonary, critical care, and sleep medicine.
ATS Foundation Thanks 2015 Contributors
The ATS Foundation is pleased to recognize our generous donors who contributed to the Foundation’s Funds for the Future Annual Campaign from Jan 1, 2015, to Dec 31, 2015.
Practice Essentials for Non-IPF ILD
The broad category of interstitial lung disease (ILD) comprises idiopathic and non-idiopathic pulmonary fibrosis (IPF), with the latter making up most of the cases. Yet, determining which form of non-IPF a patient has is challenging for physicians because there are more than 200 non-IPF ILDs.
Programs Bolster Early Career Professionals
The ATS Fellows Track Symposium, Resident Boot Camp, and Student Scholars Program have become so popular with early career professionals that attendance has increased each year.